RT-149
|
Acquired QT syndrome. The mechanistic background
|
|
|
Wilhelm Haverkamp, Paulus Kirchhof, Lars Eckardt, Gerold Mönnig, Martin Borggrefe, Günter Breithardt.
Hospitalof the Westfälische Wilhelms-University, Department of Cardiology and Angiology and Institute for Arteriosclerosis Research, Münster, Germany
|
|
References
|
1.
|
HAVERKAMP W, SHENASA M, BORGGREFE M, BREITHARDT G:
Torsade de pointes.
In: ZIPES DP, JALIFE J (eds): Cardiac electrophysiology. From cell to bedside.
Philadelphia, W.B. Saunders Company, 1995; 885-899.
|
2.
|
RODEN DM:
Taking the “idio” out of “idiosyncratic”: predicting torsades de pointes.
Pacing Clin Electrophysiol 1998; 21: 1029-1034.
|
3.
|
EL-SHERIF N, CHINUSHI M, CAREF EB, RESTIVO M:
Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns.
Circulation 1997; 96: 4392-4399.
|
4.
|
YANG T, RODEN DM:
Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence.
Circulation 1996; 93: 407-411.
|
5.
|
SCHULZE-BAHR E, GUICHENEY P, SZAFRANSKI P, ET AL:
Mutations in cardiac ion channel genes associated with acquired long-QT-syndrome.
1999; submitted.
|
6.
|
ECKARDT, L, HAVERKAMP, W, MERTENS, H, JOHNA, R, CLAGUE, JR, BORGGREFE, M, BREITHARDT G:
Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
J Cardiovasc Pharm 1998; 32: 425-434.
|
